1471-2407

BMC Cancer

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 16288 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact16288 DOIs
2

Add abstracts to 10721 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact10721 DOIs
3

Add license metadata to 1649 records

License metadata tells indexers and readers how each article may be reused.

Low impact1649 DOIs

DOIs for this ISSN

Showing the top 5 of 10000 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Incidence of bone metastases in patients with solid tumors:… (10.1186/s12885-017-3922-0)
Abstract ORCID License
188.79 328
2 Diagnostic and prognostic value of CEA, CA19–9, AFP and CA12… (10.1186/s12885-017-3738-y)
Abstract ORCID License
186.85 309
3 ESOPEC: prospective randomized controlled multicenter phase… (10.1186/s12885-016-2564-y)
Abstract ORCID License
185.46 296
4 Doxorubicin resistance in breast cancer cells is mediated by… (10.1186/s12885-017-3953-6)
Abstract ORCID License
185.46 296
5 Molecular chess? Hallmarks of anti-cancer drug resistance (10.1186/s12885-016-2999-1)
Abstract ORCID License
184.90 291
6 Mechanism of recipient cell-dependent differences in exosome… (10.1186/s12885-017-3958-1)
Abstract ORCID License
181.12 259
7 An elevated expression of serum exosomal microRNA-191, − 21,… (10.1186/s12885-018-4006-5)
Abstract ORCID License
175.53 218
8 The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy al… (10.1186/s12885-017-3918-9)
Abstract ORCID License
173.38 204
9 Safety and feasibility of fasting in combination with platin… (10.1186/s12885-016-2370-6)
Abstract ORCID License
171.59 193
10 A systematic investigation of the maximum tolerated dose of… (10.1186/s12885-017-3677-7)
Abstract ORCID License
166.70 166
11 Potential mechanisms of resistance to venetoclax and strateg… (10.1186/s12885-017-3383-5)
Abstract ORCID License
165.91 162
12 Clinically node negative breast cancer patients undergoing b… (10.1186/s12885-017-3443-x)
Abstract ORCID License
165.31 159
13 Myeloproliferative neoplasms (MPNs) have a significant impac… (10.1186/s12885-016-2208-2)
Abstract ORCID License
165.10 158
14 Better survival in right-sided versus left-sided stage I - I… (10.1186/s12885-016-2412-0)
Abstract ORCID License
165.10 158
15 Prognostic impact of circulating tumor cell apoptosis and cl… (10.1186/s12885-016-2406-y)
Abstract ORCID License
162.99 148
16 Prognostic significance of tumor infiltrating immune cells i… (10.1186/s12885-017-3317-2)
Abstract ORCID License
162.99 148
17 HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzu… (10.1186/s12885-016-2385-z)
Abstract ORCID License
161.88 143
18 Prognostic significance of BRAF and NRAS mutations in melano… (10.1186/s12885-017-3529-5)
Abstract ORCID License
161.65 142
19 Curcumin decreases malignant characteristics of glioblastoma… (10.1186/s12885-017-3058-2)
Abstract ORCID License
160.73 138
20 ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEso… (10.1186/s12885-017-3386-2)
Abstract ORCID License
158.04 127
21 Validation of the German version of the Mediterranean Diet A… (10.1186/s12885-017-3337-y)
Abstract ORCID License
157.79 126
22 Performance of a prognostic 31-gene expression profile in an… (10.1186/s12885-018-4016-3)
Abstract ORCID License
157.79 126
23 The impact of disease-related symptoms and palliative care c… (10.1186/s12885-016-2410-2)
Abstract ORCID License
157.53 125
24 MiR-9, miR-21, and miR-155 as potential biomarkers for HPV p… (10.1186/s12885-017-3642-5)
Abstract ORCID License
155.39 117
25 Prevalence and prognostic implications of psychological dist… (10.1186/s12885-017-3260-2)
Abstract ORCID License
155.11 116
26 Genistein induces apoptosis of colon cancer cells by reversa… (10.1186/s12885-017-3829-9)
Abstract ORCID License
155.11 116
27 Weight change during chemotherapy in breast cancer patients:… (10.1186/s12885-017-3242-4)
Abstract ORCID License
154.83 115
28 Prevalence of pathogenic BRCA1/2 germline mutations among 80… (10.1186/s12885-018-4029-y)
Abstract ORCID License
154.83 115
29 Droplet digital PCR for detection and quantification of circ… (10.1186/s12885-017-3424-0)
Abstract ORCID License
154.55 114
30 Comprehensive evaluation of NT5E/CD73 expression and its pro… (10.1186/s12885-018-4073-7)
Abstract ORCID License
154.55 114
31 Role of HLA-G and extracellular vesicles in renal cancer ste… (10.1186/s12885-015-2025-z)
Abstract ORCID License
154.27 113
32 Cribriform and intraductal prostate cancer are associated wi… (10.1186/s12885-017-3976-z)
Abstract ORCID License
153.10 109
33 Feasibility and acceptability of combining cognitive behavio… (10.1186/s12885-017-3892-2)
Abstract ORCID License
152.51 107
34 A multicentre randomised controlled trial to evaluate the ef… (10.1186/s12885-017-3200-1)
Abstract ORCID License
152.20 106
35 The prognostic value of the preoperative c-reactive protein/… (10.1186/s12885-017-3220-x)
Abstract ORCID License
151.90 105
36 MCM family in HCC: MCM6 indicates adverse tumor features and… (10.1186/s12885-018-4056-8)
Abstract ORCID License
151.59 104
37 Factors associated with breast cancer recurrences or mortali… (10.1186/s12885-018-4076-4)
Abstract ORCID License
151.59 104
38 Aberrant KDM5B expression promotes aggressive breast cancer… (10.1186/s12885-016-2108-5)
Abstract ORCID License
151.28 103
39 Long non-coding RNA XIST regulates PTEN expression by spongi… (10.1186/s12885-017-3216-6)
Abstract ORCID License
151.28 103
40 Low level laser therapy (Photobiomodulation therapy) for bre… (10.1186/s12885-017-3852-x)
Abstract ORCID License
151.28 103
41 L-Arginine supplementation inhibits the growth of breast can… (10.1186/s12885-016-2376-0)
Abstract ORCID License
150.65 101
42 The evidence base for circulating tumour DNA blood-based bio… (10.1186/s12885-017-3693-7)
Abstract ORCID License
150.65 101
43 Cannabis exposure and risk of testicular cancer: a systemati… (10.1186/s12885-015-1905-6)
Abstract ORCID License
150.00 99
44 Women’s experience with home-based self-sampling for human p… (10.1186/s12885-015-1804-x)
Abstract ORCID License
149.67 98
45 Systematic review: brain metastases from colorectal cancer—I… (10.1186/s12885-016-2290-5)
Abstract ORCID License
149.34 97
46 M1 and M2 macrophages derived from THP-1 cells differentiall… (10.1186/s12885-015-1546-9)
Abstract ORCID
149.02 955
47 Acupuncture combined with methylcobalamin for the treatment… (10.1186/s12885-016-3037-z)
Abstract ORCID License
149.01 96
48 Gamma-glutamyltransferase activity in exosomes as a potentia… (10.1186/s12885-017-3301-x)
Abstract ORCID License
149.01 96
49 Diabetes and risk of cancer incidence: results from a popula… (10.1186/s12885-017-3696-4)
Abstract ORCID License
148.33 94
50 Long-term outcomes of ductal carcinoma in situ of the breast… (10.1186/s12885-015-1904-7)
Abstract ORCID License
147.98 93